A 5.8% compound annual growth rate (CAGR) is projected for the global mobile tomography market from 2022 to 2032, with 2022 revenues of US$ 295.2 Million and 2032 revenues of US$ 595.1 Million. The growth of the market is being sustained by:
| Report Attribute | Details |
|---|---|
| Mobile Tomography Market Value (2022) | US$ 295.2 Million |
| Mobile Tomography Market Anticipated Value (2032) | US$ 595.1 Million |
| Mobile Tomography Projected Growth Rate (2032) | 5.8% |
The expansion of this sector could be stymied by the fact that transportable computed tomography scanners have been linked to health problems like headaches and nausea. The mobile tomography market is expected to expand due to the device's ease of use and portability.
The use of portable CT scanners in healthcare settings has been quite fruitful. Successful applications of CT scanner technology in malignancies, trauma, unexplained chronic headache, and disease staging have created new growth prospects for the mobile tomography market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
OmniTom is Samsung's newest proof of its superiority in the mobile tomography market. In comparison to Samsung's previous generation CereTom CT scanner, the newer OmniTom model, has several notable upgrades, such as:
Next-generation CT technologies include Samsung's spectral CT with Photon Counting Detector (PCD). The healthcare solutions presented by the Samsung team include mobile CT, digital radiography, and ultrasound, all of which aim to close the gap in care delivery and increase productivity for a better patient experience. Solutions like these include:
In the ultrasound market, Samsung will showcase its whole line of ultrasound equipment, including the recently released HS60 and HS40. Three daily instructional presentations with live scanning will showcase the RS80A with Prestige, Samsung's top-tier general-imaging ultrasound system. The RS80A's cutting-edge features are a welcome boon to clinical confidence in a department as high-volume as radiology. The company is building on its success in obstetrics and gynecology ultrasonic diagnosis equipment to expand into radiology, the sector with the most promising future.
In the digital radiography market, Samsung will showcase an extensive product line-up, including the GC85 and GC70, two ceiling-mounted systems, and the GM85, a premium portable X-ray. Users will enjoy unprecedented productivity and stunning visuals because of the GM85's improved portability and simpler workflow. Samsung's low-dose technology, which aims to improve patient safety, is another way it stands apart from the competition.
Samsung will display an early model of their Specialty MRI equipment, an MRI scanner designed to image extremities. The prototype is being heralded as a game-changer in the business because of its innovative approach to MRI scanning that reduces the need for patients to place their entire bodies within the machine, saving both time and money.
Principal Consultant
As a result of several valid concerns about cost and access, mobile CT scanners are increasingly favored over permanently installed ones in hospitals. Healthcare providers in some regions, such as North America, are opting to use mobile CT scanners rather than permanently installed ones due to the long wait times and high costs associated with purchasing fixed CT. Key advantages include less work for medical staff, shorter hospital stays, faster access to CT for outpatients, and quicker provision of essential services for inpatients. This is changing the global mobile tomography market outlook.
Patients appreciate CT scanners largely because they don't require any patient interaction beyond looking at the image on the screen. High adaptability and decreased operating and capital costs propel the CT scanners market. Mobile tomography market growth can be directly attributed to these devices' superior safety and sensitivity.
One trend helping to create opportunities in the mobile tomography market is the rising demand for mobile CT scanners in diagnostic services in both emerging and developed countries. The increasing adoption of mobile tomography to diagnose and treat neurological disorders is a major factor driving market growth. As a result of their low risk of infection and recovery time, mobile CT scanners have become increasingly popular.
However, the mobile tomography market is likely to be stymied by factors such as a clearly defined regulatory framework and a lack of suitable reimbursement. High product costs and one-time installations at individual facilities slow the mobile tomography market's expansion.
Since mobile tomography is still a novel service, a lack of trained specialists is expected to restrain the industry's expansion further. Additionally, mobile tomography is projected to have slow mobile tomography market expansion because of specific adverse effects, such as nausea and headache.
Due to factors such as increasing demand for healthcare services and diagnostic centers, as well as greater public knowledge about the importance of early disease detection, the regional North American mobile tomography market is anticipated to expand rapidly throughout the forecast period.
Greater access to high-quality medical care in industrialized nations is a major factor in why these economies generate more money than those in the developing world.
Due to factors such as the region's developing healthcare infrastructure, rising chronic disease rates, rising disposable incomes, the strength of home-grown businesses, and the rapid growth of the region's elderly population, the Asia-Pacific region presents lucrative opportunities for leaders in the mobile tomography market. The expansion of Asia's mobile tomography market is anticipated to be bolstered by the improving economies of emerging markets like India and China. More government efforts to build new community health and oncology centers are expected to enhance the use of mobile medical imaging in underserved areas
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The future of the mobile tomography market is anticipated to be shaped by the key developments of new firms. Manufacturers in the mobile tomography market are investing heavily in Research and Development to produce increasingly sophisticated mobile tomography solutions, opening numerous potential opportunities in the market. Mobile tomography is expected to increase as a market since it is widely favored by patients who have suffered a stroke due to the short time required for scanning.
Start-up company FITPU healthcare has created an image analytics platform called Mltalytics. Tissue analysis for malignant tumors is performed, and dynamic contrast-enhanced and multi-parametric imaging is supported.
Some of the key players in mobile tomography are
| Report Attribute | Details |
|---|---|
| Growth Rate | 5.8% |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Number of Slices, Application, End-User, Region |
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
North America is anticipated to lead the mobile tomography market during the forecast period.
The mobile tomography market is likely to hold a valuation of US$ 595.1 Million by 2032.
The growth outlook of the mobile tomography market is predicted to advance at a CAGR of 5.8% from 2022 to 2032.
1. Executive Summary | Mobile Tomography Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyers
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2022 to 2032
5.3.1. Low Slice CT Scanner (<32 slices)
5.3.2. Medium Slice CT Scanner (32 slices)
5.3.3. High Slice CT Scanner (>32 slices)
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2022 to 2032
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Diagnostic Centers
6.3.4. Ambulatory Surgical Centers
6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2017 to 2021
7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa(MEA)
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End User
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Product Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By End User
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Malaysia
11.2.1.5. Singapore
11.2.1.6. Australia
11.2.1.7. New Zealand
11.2.1.8. Rest of Asia Pacific
11.2.2. By Product Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By End User
11.4. Key Takeaways
12. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of Middle East and Africa(MEA)
12.2.2. By Product Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By End User
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. USA
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Product Type
13.1.2.2. By End User
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Product Type
13.2.2.2. By End User
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Product Type
13.3.2.2. By End User
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Product Type
13.4.2.2. By End User
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Product Type
13.5.2.2. By End User
13.6. United Kingdom
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Product Type
13.6.2.2. By End User
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Product Type
13.7.2.2. By End User
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Product Type
13.8.2.2. By End User
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Product Type
13.9.2.2. By End User
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Product Type
13.10.2.2. By End User
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Product Type
13.11.2.2. By End User
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Product Type
13.12.2.2. By End User
13.13. Malaysia
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Product Type
13.13.2.2. By End User
13.14. Singapore
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Product Type
13.14.2.2. By End User
13.15. Australia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Product Type
13.15.2.2. By End User
13.16. New Zealand
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Product Type
13.16.2.2. By End User
13.17. GCC Countries
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Product Type
13.17.2.2. By End User
13.18. South Africa
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Product Type
13.18.2.2. By End User
13.19. Israel
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Product Type
13.19.2.2. By End User
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Product Type
14.3.3. By End User
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Xoran Technologies
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.1.5.2. Product Strategy
15.1.1.5.3. Channel Strategy
15.1.2. NeuroLogica Corp
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.2.5.2. Product Strategy
15.1.2.5.3. Channel Strategy
15.1.3. Planmed OY
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.3.5.2. Product Strategy
15.1.3.5.3. Channel Strategy
15.1.4. Brainlab AG
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.4.5.2. Product Strategy
15.1.4.5.3. Channel Strategy
15.1.5. Dixion
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.5.5.2. Product Strategy
15.1.5.5.3. Channel Strategy
15.1.6. Canon Medical Systems
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.6.5.2. Product Strategy
15.1.6.5.3. Channel Strategy
15.1.7. Siemens
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.7.5.2. Product Strategy
15.1.7.5.3. Channel Strategy
15.1.8. InHealth Group
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.8.5.2. Product Strategy
15.1.8.5.3. Channel Strategy
15.1.9. Bausch Health
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.9.5.2. Product Strategy
15.1.9.5.3. Channel Strategy
15.1.10. Samsung
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.10.5.2. Product Strategy
15.1.10.5.3. Channel Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports
Mobile Tomography Market
